Simplified Interpretation of Genomic Profiles
Smarter, Faster, Automated
Turns complex tertiary NGS reports into concise summaries, reduces manual
interpretation time and helps labs scale effortlessly.
interpretation time and helps labs scale effortlessly.
-85%
Reduction in interpretation time
7x
Cases per FTE
3x
Test orders
Our Partners
Challenges
Navigating the complexities of Genomic Data Interpretation
Genomic sequencing yields vast data, but interpreting it is time-consuming, labor-intensive, and error-prone. Healthcare providers face challenges such as:
Report Complexity
80% of oncologists complain about NGS
report complexity
report complexity
Scarce Ressource
Access to genomics specialists is a
crucial bottleneck
crucial bottleneck
Fast Paced
There are more than >170k new publications in oncology in 2022
The Qnomx solution
AI-Powered Interpretation
for Streamlined Genomic Insights
Qnomx revolutionizes genomic data interpretation by providing
Automate clinical analysis
Reduces manual effort,
saving time and costs.
Standardize
reporting
Ensures accuracy and
consistency across reports.
Boost oncologist
confidence
Delivers clear insights, increasing oncologist trust and test adoption.
Scalable
solutions
Enables labs to process more cases without additional resources.
How Qnomx Works
Upload Report
Upload the lab’s genomic profile
(tertiary analysis) report.
AI Interpretation
Our AI extracts key clinical insights through a simple, interactive interface.
Draft Clinical Summary
Qnomx provides a ready-to-review clinical summary in local language for lab approval.
Solutions for our audiences
Empowering Diverse
Stakeholders in Precision
Oncology
Solution for
Clinical Laboratories
Reduce manual effort, cut costs, and scale without adding staff.
Automates the interpretation process, standardizing clinical summary creation and reduces costs
7x more cases processing without additional resources
85% reduction in interpretation time
Solution for
Bioinformatics Companies
Make genomic reports clinically actionable and gain a competitive edge
Adds automated AI-driven interpretation to the tertiary analysis, making reports more actionable
Supports demand generation for NGS testing
Increases client satisfaction and retention, with more meaningful insights
Solution for
Oncology Clinics
Make genomic reports clinically actionable
Distills therapy-relevant insights, faster
Cuts down MTB preparation time, freeing up valuable clinical resources.
Keeps you updated with real-time clinical insights
making decision-making faster and more precise
Trusted by Leading Experts
“Based on our expertise in molecular pathology and genetic testing, we see significant potential in CGC Genomics’ Qnomx platform to further optimize the interpretation of complex genomic data. This partnership allows us to increase the efficiency and quality of our NGS process and make a valuable contribution to precision medicine.“
Marc Becker, Managing Director of Labor Becker MVZ eGbR
Our Team
James Creeden MD, PhD
Co-Founder & Co-CEO
Joerg Hoelzing MBA, PhD
Co-Founder & Co-CEO
Marcus Olivecrona, MSc
Co-Founder & CTO
Our Mission
Advancing Precision
Oncology
Oncology
We are dedicated to ensuring every cancer patient receives optimal care by providing reliable and actionable genomic insights, empowering oncologists to make informed treatment decisions.
Our Expertise
Navigating Complex
Genomic Data
Genomic Data
With years of experience analyzing thousands of intricate cancer genomics cases worldwide, our team excels in interpreting complex genomic data, bridging the gap between raw data and clinical application.
Our Commitment
Realizing the Potential
of
Genomic Medicine
Genomic Medicine
We believe that the full potential of precision oncology is achieved through accurate and effective genomic data interpretation. Our mission is to provide comprehensive and precise analyses of genomic testing results, ensuring that complex data translates into meaningful patient care.
FAQs
What does Qnomx do?
Qnomx is an AI-powered platform that automates the interpretation of cancer genomic profiles. It transforms complex NGS reports into concise, clinically actionable summaries to help oncology labs and oncologists make faster, clearer treatment decisions.
What makes Qnomx different from existing bioinformatics platforms?
Bioinformatics platforms process sequencing data and generate comprehensive genomic reports as the result of the tertiary analysis. We are complementary by adding the missing step: automated interpretation of these reports into concise, actionable clinical summaries, delivered in the lab’s local language. This helps labs reduce manual workload, accelerate turnaround times, and improve the clarity of results for their clinical partners.
Can Qnomx integrate with existing lab workflows?
Yes, Qnomx is designed for fast adoption. Labs can simply upload genomic reports via a web interface or API without the need for deep integration into LIMS, EMR, or EHR systems. No data mapping or workflow overhaul required.
How does Qnomx ensure high-quality interpretations?
Qnomx uses proprietary AI models trained on curated datasets and trusted clinical sources such as ClinVar, COSMIC, NCCN, OncoKB, HGMD, GENIE, CIVIC, and peer-reviewed literature. Our clinical insights are further strengthened by over 15,000 hours of hands-on experience from our team in interpreting complex cancer genomic cases, ensuring consistent and clinically relevant outputs.
Does Qnomx cover all types of cancer?
Yes, Qnomx is cancer-agnostic and supports all metastatic cancer indications where NGS sequencing is used, helping labs and clinicians across a wide range of oncology cases.
What data does Qnomx use for the interpretation – FASTQ, VCF, or the tertiary analysis?
Qnomx starts once the tertiary analysis is completed and a finalized genomic profile report is available. We do not process FASTQ or VCF files. Instead, we interpret the completed report generated by the lab’s bioinformatics pipeline to deliver clinical summaries and treatment recommendations.
Ready to Automate Genomic Interpretation?
Join the future of precision medicine with AI-powered genomic insights.
